AVEO PHARMACEUTICALS, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2001-01-01
- Employees
- 115
- Market Cap
- -
- Website
- http://www.aveooncology.com
A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-11-26
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- AVEO Pharmaceuticals, Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT00563147
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸The Methodist Hospital Research Institute, Houston, Texas, United States
🇺🇸UCLA Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients
- First Posted Date
- 2007-10-31
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- AVEO Pharmaceuticals, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT00551850
- Locations
- 🇺🇸
Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸Kansas Masonic Cancer Research Center, Kansas City, Kansas, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-07-17
- Last Posted Date
- 2020-09-01
- Lead Sponsor
- AVEO Pharmaceuticals, Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT00502307
Safety/Tolerability Study of AV-412 in Subjects With Refractory or Relapsed Solid Tumor Malignancies
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2011-10-04
- Lead Sponsor
- AVEO Pharmaceuticals, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT00381654
- Locations
- 🇦🇷
Hospital Universitatrio Austral, Buenos Aires, Argentina
🇦🇷Instituto Médico Especializado Alexander Fleming, Buenos Aires, Argentina
🇺🇸Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
© Copyright 2024. All Rights Reserved by MedPath